Literature DB >> 110919

Acetazolamide binding to two carbonic anhydrase isoenzymes in human erythrocytes.

W F Bayne, L C Chu, F Theeuwes.   

Abstract

Acetazolamide binding to high activity and low activity carbonic anhydrase isoenzymes in red blood cells was studied. Inhibitory constants of 0.041 and 2.72 microM and maximum binding capacities of 17.2 and 155 microM, respectively, were found.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 110919     DOI： 10.1002/jps.2600680736

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


  10 in total

1.  Uptake and stereoselective binding of the enantiomers of MK-927, a potent carbonic anhydrase inhibitor, by human erythrocytes in vitro.

Authors:  J H Lin; T H Lin; H Cheng
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

2.  A semi-physiological population pharmacokinetic model describing the non-linear disposition of indisulam.

Authors:  Anthe S Zandvliet; Jan H M Schellens; William Copalu; Jos H Beijnen; Alwin D R Huitema
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-09-01       Impact factor: 2.745

3.  Dose-dependent pharmacokinetics of MK-417, a potent carbonic anhydrase inhibitor, in experimental polycythemic and anemic rats.

Authors:  J H Lin; I W Chen; F A deLuna
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

4.  Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence.

Authors:  Aidan J Hampson; Jennifer R Schroeder; Kayla N Ellefsen; Luba Yammine; David H Epstein; Kenzie L Preston; Marilyn A Huestis; Christopher D Verrico
Journal:  Clin Pharmacol Ther       Date:  2020-07-11       Impact factor: 6.875

5.  In vitro characterization of the erythrocyte distribution of methazolamide: a model of erythrocyte transport and binding kinetics.

Authors:  G R Iyer; R A Bellantone; D R Taft
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

6.  A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical Trials.

Authors:  Aidan J Hampson; Shanna Babalonis; Michelle R Lofwall; Paul A Nuzzo; Phillip Krieter; Sharon L Walsh
Journal:  J Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.153

7.  Pethidine binding to blood cells and plasma proteins in old and young subjects.

Authors:  L Holmberg; I Odar-Cederlöf; J L Nilsson; M Ehrnebo; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Binding of sulfonamides to carbonic anhydrase: influence on distribution within blood and on pharmacokinetics.

Authors:  A Boddy; P Edwards; M Rowland
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

9.  Evolution and diversity of alpha-carbonic anhydrases in the mantle of the Mediterranean mussel (Mytilus galloprovincialis).

Authors:  João C R Cardoso; Vinicius Ferreira; Xushuai Zhang; Liliana Anjos; Rute C Félix; Frederico M Batista; Deborah M Power
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

10.  UHPLC-HRMS Method for the Simultaneous Screening of 235 Drugs in Capillary Blood for Doping Control Purpose: Comparative Evaluation of Volumetric and Non-volumetric Dried Blood Spotting Devices.

Authors:  Monica Mazzarino; Ludovica Di Costanzo; Fabio Comunità; Carlotta Stacchini; Xavier de la Torre; Francesco Botrè
Journal:  ACS Omega       Date:  2022-08-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.